Clinical Trials · NCT07056803
Oral vs. Subcutaneous Semaglutide in Type 2 Diabetes Mellitus
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Palermo
- Enrollment
- 212
- Start date
- Jan 2024
- Locations
- 1 site, Italy
- Primary endpoint
- Number of participants with HbA1c change